- Cardiac Toxicities Associated with Immune Checkpoints Inhibitors: Mechanisms, Manifestations and Management
-
Zarifa A, Kim JW, Lopez-Mattei J, Palaskas N, Iliescu C, Kim PY
- KMID: 2517487
- Korean Circ J.
- 2021 Jul;51(7):579-597.
- doi: 10.4070/kcj.2021.0089
Immune checkpoint inhibitor (ICI) associated cardiovascular adverse events (CVAE) have become more frequent with the growing use of cancer immunotherapy. CVAEs include a wide spectrum of diseases such as myocarditis,... -
- CITED
-
- Close
- SHARE
-
- Close
